Cancer susceptibility candidate 2 (CASC2) acts as a tumor suppressor by targeting miR‐155, restoring suppressors of cytokine signaling 1 (SOCS1) expression and inhibiting HCC proliferation.58 Here, SOCS1 is linked to hepatocellular carcinoma.